10026 Results for "

Modification

" in MedChemExpress (MCE) Product Catalog:
Products (10026)

10026 Results for "Modification" in MCE Product Catalog:

Cat. No.: HY-174961
Synonyms: Fmoc-NH-PEG1000-Mal
Fmoc-PEG1000-Maleimide (Fmoc-NH-PEG1000-Mal) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
loading...
    loading...
Cat. No.: HY-174961A
Synonyms: Fmoc-NH-PEG2000-Mal
Fmoc-PEG2000-Maleimide (Fmoc-NH-PEG2000-Mal) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
loading...
    loading...
Cat. No.: HY-174961B
Synonyms: Fmoc-NH-PEG3400-Mal
Fmoc-PEG3400-Maleimide (Fmoc-NH-PEG3400-Mal) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
loading...
    loading...
Cat. No.: HY-174961C
Synonyms: Fmoc-NH-PEG5000-Mal
Fmoc-PEG5000-Maleimide (Fmoc-NH-PEG5000-Mal) is a PEG derivative with an Fmoc protecting group and a Maleimide (HY-W007324) reactive group. Fmoc is a commonly used amino protecting group that protects the amino group from unwanted reactions until it is removed for a specific coupling reaction. Maleimide forms a stable thioether bond with sulfhydryl (-SH) groups. PEG modification can improve solubility and stability and reduce the immunogenicity of proteins and peptides .
loading...
    loading...
Cat. No.: HY-184637
DMSA Coated Fe2O3 Nanoparticles (Carboxylated ferric oxide nanoparticles) are magnetic nanomaterials with carboxyl (-COOH) groups modified on their surface. These materials typically consist of ferric oxide (Fe2O3) nanoparticles as a core, with carboxyl functional groups introduced to the surface through chemical modification. The carboxylation of the nanoparticle surface increases its negative surface charge, contributing to improved solubility and stability in water. Carboxylated ferric oxide nanoparticles exhibit good biocompatibility, making them suitable for biomedical applications.
loading...
    loading...
Cat. No.: HY-184913
Target:  

PROTACs CDK

Research Areas:  

Cancer

JHK-02-102-1 is a selective CDK5 degrader derived from the regorafenib kinase inhibitor scaffold. JHK-02-102-1 recruits CRL4CRBN E3 ubiquitin ligase to induce ternary complex formation between CDK5 and CRBN, triggering ubiquitin-proteasome system-dependent degradation. JHK-02-102-1 achieves selectivity redirection from CDK6 to CDK5 via subtle PROTAC architecture modifications .
loading...
    loading...
Cat. No.: HY-185104
CAS No.: 2861254-89-7
Target:  

LXR

Research Areas:  

Cardiovascular Disease

Ginsenoside C-K hexapropionate ester (Structure 2) is a selective agonist of LXRα, with no significant activation effect on LXRβ. Ginsenoside C-K hexapropionate ester upregulates the expression of downstream genes such as ABCA1 by activating LXRα, promoting reverse cholesterol transport, and reducing lipid deposition in macrophage-derived foam cells. It can be used in the research of atherosclerosis. Ginsenoside C-K hexapropionate ester is a derivative synthesized from ginsenoside Compound K, an active metabolite of Panax notoginseng saponins, by modification with propionic anhydride .
loading...
    loading...
Cat. No.: HY-187493A
Synonyms: DOPE-PEG2000-Mal-Cys-DHLASLWWGTEL
Research Areas:  

Others

DOPE-PEG2000-DHLASLWWGTEL (DOPE-PEG2000-Mal-Cys-DHLASLWWGTEL) is an amphiphilic lipid-PEG-peptide conjugate composed of DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), PEG2000, and the DHLASLWWGTEL peptide, a 12-amino-acid tissue-targeting peptide identified through phage display. DOPE-PEG2000-DHLASLWWGTEL is used for targeted drug delivery through liposome and nanoparticle surface modification.
loading...
    loading...
Cat. No.: HY-N0086S
CAS No.: 139896-43-8
Synonyms: 6-Methyladenosine-d3; N-Methyladenosine-d3
N6-Methyladenosine-d3 (6-Methyladenosine-d3; N-Methyladenosine-d3) is a deuterium labeled N6-Methyladenosine (HY-N0086). N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities.
loading...
    loading...
Cat. No.: HY-N0086S2
Synonyms: 6-Methyladenosine-13C4; N-Methyladenosine-13C4
N6-Methyladenosine- 13C4 (6-Methyladenosine- 13C4; N-Methyladenosine- 13C4) is 13C-labeled N6-Methyladenosine (HY-N0086). N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities.
loading...
    loading...
Cat. No.: HY-N0086S3
Synonyms: 6-Methyladenosine-13C3; N-Methyladenosine-13C3
N6-Methyladenosine- 13C3 (6-Methyladenosine- 13C3) is 13C-labeled N6-Methyladenosine (HY-N0086). N6-Methyladenosine is the most prevalent internal (non-cap) modification present in the messenger RNA (mRNA) of all higher eukaryotes. N6-Methyladenosine can modifies viral RNAs and has antiviral activities .
loading...
    loading...
Cat. No.: HY-P5514
CAS No.: 409085-42-3
Synonyms: Amylin (22-27) [NMeG24, NMeI26], human (IAPP)
Target:  

Inhibitory Antibodies

Research Areas:  

Others

NF(N-Me)GA(N-Me)IL is a biological active peptide. (This amino acids 22 to 27 fragment is a modification of the human islet amyloid polypeptide hIAPP (NFGAIL) with N-methylation of the amide bonds at G24 and I26. The introduction of two N-methyl rests in the amyloid-core-containing sequence NFGAIL converts this amyloidogenic and cytotoxic sequence into non-amyloidogenic and non-cytotoxic peptide. The peptide is able to bind with high-affinity full-length hIAPP and to inhibit its fibrillogenesis.)
loading...
    loading...
Cat. No.: HY-R00010A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-let-7f-1-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
loading...
    loading...
Cat. No.: HY-R00011A
Target:  

MicroRNA

hsa-let-7f-2-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
loading...
    loading...
Cat. No.: HY-R00158A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-1255b-2-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
loading...
    loading...
Cat. No.: HY-R00165A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-125b-1-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
loading...
    loading...
Cat. No.: HY-R00166A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-125b-2-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
loading...
    loading...
Cat. No.: HY-R00330A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-181b-2-3p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
loading...
    loading...
Cat. No.: HY-R00403A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-19b-2-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
loading...
    loading...
Cat. No.: HY-R00512A
Target:  

MicroRNA

Research Areas:  

Cancer

hsa-miR-29b-1-5p agomirs are chemically-modified double-strand miRNA mimics with modified mature miRNA strand: 2 phosphorothioates at the 5' end, 4 phosphorothioates at the 3' end, 3' end cholesterol group, and full-length nucleotide 2'-methoxy modification. They are designed to mimic endogenous miRNAs and recommended for miRNA functional studies. Compared with miRNA mimics, they exhibits enhanced cellular uptake, stability and regulatory activity in vivo.
loading...
    loading...